clinical trial · NCT07882472
A Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.
Healthy AdultDTI-117Placebo
brief summary
This is a single ascending dose, double-blind, placebo-controlled, randomized evaluation of the safety, tolerability, and pharmacokinetics of DTI-117 in healthy volunteers. There will be up to five cohorts of 8 healthy participants each cohort.
started
Oct 1, 2026
primary completion
Feb 1, 2027
completion
Apr 1, 2027
last updated
Oct 26, 2026
official title
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Pharmacokinetics of Single Intramuscular (IM) Doses of DTI-117 in Healthy Participants.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol